Home > Insider Trading > Filing (0001415889-24-015315)

Filing Details

Accession Number:: 0001415889-24-015315
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-06-04 16:00:06
Reporting Period:: 2024-05-31

Accepted Time:: 2024-06-04 16:00:06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1597264	Blueprint Medicines Corp	BPMC	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1840110	Becker L. Hewes	C/O Blueprint Medicines Corporation 45 Sidney Street Cambridge MA 02139	Chief Medical Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2024-05-31	10,573	$66.24	56,854	No	4	M	Direct
Common Stock	Acquisiton	2024-05-31	8,385	$61.31	65,239	No	4	M	Direct
Common Stock	Acquisiton	2024-05-31	5,729	$43.15	70,968	No	4	M	Direct
Common Stock	Disposition	2024-05-31	3,671	$107.86	67,297	No	4	S	Direct
Common Stock	Disposition	2024-05-31	3,191	$106.50	64,106	No	4	S	Direct
Common Stock	Disposition	2024-05-31	20,904	$105.81	43,202	No	4	S	Direct
Common Stock	Disposition	2024-05-31	6,342	$104.83	36,860	No	4	S	Direct
Common Stock	Disposition	2024-06-03	2,971	$106.43	33,889	No	4	S	Direct
Common Stock	Disposition	2024-06-03	1,951	$106.43	31,938	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to Buy)	Disposition	2024-05-31	10,573	$0.00	10,573	$66.24
Common Stock	Stock Options (Right to Buy)	Disposition	2024-05-31	8,385	$0.00	8,385	$61.31
Common Stock	Stock Options (Right to Buy)	Disposition	2024-05-31	5,729	$0.00	5,729	$43.15

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
13,490	2030-06-01	No	4	M	Direct
9,115	2032-03-01	No	4	M	Direct
19,271	2033-03-01	No	4	M	Direct

Footnotes

Effected pursuant to a trading plan adopted on March 1, 2024 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $107.50 to $108.31 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) through (5) in this form 4.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $106.24 to $107.20 per share.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $105.22 to $106.20 per share.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $104.43 to $105.20 per share.
The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
This option was granted on June 1, 2020. This option vested with respect to 25% of the shares underlying the option on June 1, 2021 and as to an additional 1/48th of the shares underlying the option each month thereafter.
This option was granted on March 1, 2022. This option vested with respect to 1/48th of the shares underlying the option on April 1, 2022 and as to an additional 1/48th of the shares underlying the option each month thereafter.
This option was granted on March 1, 2023. This option vested with respect to 1/48th of the shares underlying the option on April 1, 2023 and as to an additional 1/48th of the shares underlying the option each month thereafter.